Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(1.05) per share. This is a 85.38 percent increase over losses of $(7.18) per share from the same period last year.
Baudax Bio Q2 EPS $(1.05) Up From $(7.18) YoY
Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(1.05) per share. This is a 85.38 percent increase over losses of $(7.18) per share from the same period last year.
Related Posts
Tesla Makes Referral Program Less Rewarding For Model S/X Buyers, Referrers
September 7, 1:11 AM
Tesla Inc (NASDAQ:TSLA) has changed the terms of its referral program to make it uniform across models and…
Earnings Outlook For Sherwin-Williams
January 25, 11:02 AM
Sherwin-Williams (NYSE:SHW) is set to give its latest quarterly earnings report on Thursday, 2023-01-26. Here’s what investors need…
Alibaba Falls, Nio Rises: Hang Seng Opens Strong As Investors Eye China Trade Data, U.S. Mid-Terms
November 6, 10:33 PM
Hong Kong stocks opened in the green on Monday morning, with the benchmark Hang Seng gaining over 1%, as investors shifted their focus toward U.S. mid-term elections and China trade data due later today.